Technical Assistance and Provision for Foreign Hospitals and Health Organizations

 

To provide support for a quality of care improvement project based in a partner healthcare institution around the world, to provide continuing education and refresher training to physicians and other staff at hospitals and other Health Organizations around the world, and strengthen support and relations with Ministers of Public Health (MOPH).

Active 93.019 Office of The Secretary, Department of Health and Human Services B - Project Grants; Z - Salaries and Expenses Not applicable. The Omnibus Appropriations Act, 2009, appropriated funds to HHS for carrying out Title III of the Public Health Service Act (PHS Act). Public Law 111-8, 123 Stat. 524, 777 (March 11, 2009). b. Pursuant to Section 307(a)(2) of the PHS Act, 42 U.S.C. Section 242l(a)(2), HHS is authorized to participate with other countries in cooperative endeavors in biomedical research, health care services, health care research, or other related activities in furtherance of the activities, objectives or goals authorized under the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (PEPFAR Reauthorization Act). The purpose of the PEPFAR Reauthorization Act, 22 U.S.C. Section 7603, is “to strengthen and enhance United States leadership and the effectiveness of the United States response to the HIV/AIDS, tuberculosis, and malaria pandemics and other related and preventable infectious diseases as part of the overall United States health and development agenda.”, 42 U.S.C. 242l(a)(2) none Citizens of the world. Not applicable. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. All grant announcements are posted on www.grants.gov. Applications will be screened upon receipt. Those that are judged to be incomplete or arrive after the deadline will be returned without comment. Accepted applications will be reviewed for technical merit in accordance with HHS policies. Applications will be evaluated by a technical review panel composed of experts. Funding decisions will be determined by the Director, Office of Global Health Affairs and will take into consideration the recommendations and ratings of the review panel; program needs, and stated preferences. Contact the headquarters or regional location, as appropriate for application deadlines From 30 to 60 days. Approximately 60 days from the application deadline date. Not applicable. More than 180 days. Support is recommended for a specified project period (5 years), and is not generally considered for renewal beyond that period. Applications will be screened by OGHA staff for completeness and for responsiveness to the program guidance. Applicants should pay strict attention addressing these criteria, as they are the basis upon which applications will be judged. Those applications judged to be non-responsive or incomplete will be returned to the applicant without review. Applications that are complete and responsive to the guidance will be evaluated for scientific and technical merit by an appropriate peer review group specifically convened for this solicitation and in accordance with HHS policies and procedures. As part of the initial merit review, all applications will receive a written critique. All applications recommended for approval will be discussed fully by the ad hoc peer review group and assigned a priority score for funding. Eligible applications will be assessed according the following criteria: Technical Approach 45 points; Experience and Capabilities of the Organization 45 points; and Facilities and Resources 10 points. Funds may be used to cover costs of: personnel; consultants; grant related office supplies and software; grant related travel (domestic only); educational, promotional and evaluation materials; and other grant related costs. Funds shall not be used to fund direct health care services or equipment for patients (e.g., diagnostic tests, screening equipment, treatment, etc.). Also, funds may not be used for: building alterations or renovations, construction, screening supplies or equipment, incentives and prizes, food, fund raising activities, political education and lobbying, and other activities that are not grant related. Performance Reports: A final performance report is due 90 days following the end of the project period. Reference FOA for Audit Requirements. HHS and the Comptroller General of the United States or any of their authorized representatives, shall have the right of access to any books, documents, papers, or other records of a grantee, subgrantee, contractor, or subcontractor, which are pertinent to the HHS grant, in order to make audits, examinations, excerpts and transcripts. In accordance with 45 CFR Part 75, grantees are required to maintain grant accounting records 3 years after the end of a budget period. If any litigation, claim, negotiation, audit or other action involving the records has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Varies, but a project period is generally limited to 5 years or less. Within a project period, continuation applications must be submitted annually on a noncompeting basis for each year of support. Method of awarding/releasing assistance: Quarterly. Program Management Contact: Biomedical Advanced Research and Development Authority (BARDA) Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services Julie Schafer
200 Independence Ave., SW,
Washington, DC 20201 US
Julie.Schafer@hhs.gov
Phone: 202-205-1435

Donna Boston
200 Independence Ave. SW,
Washington, DC 20024 USA
Donna.Boston@hhs.gov
Phone: 202-823-2087 http://www.phe.gov 75-0120-0-1-551 (Salaries and Expenses) FY 18$1,760,969.00; FY 19 est $1,300,000.00; FY 20 est $1,300,000.00; FY 17 est $0.00; FY 16$0.00; - $650,000.00 to $7,900,000 45 CFR 75. Specific program requirements are contained in the Federal Register Notice, the application instructions, and the HHS Grants Policy Statement. Not applicable.